Catalyst Wire Dossier Catalyst Wire Dossier

Urotensin-II

urotensin II
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Urotensin-II, covering 2011-07-20 to 2011-07-20. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Effects of Urotensin-II and Soluble Epoxide Hydrolase Inhibitors on Skin Microvessel Tone in Patients With Heart Failure, and in Healthy Volunteers [Phase 2]

See pricing